Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NOVo-Helisen Depot HoUSe Dust Mites - A Prospective, Multicenter, Noninterventional Clinical Study on the Tolerability and Safety of Short One Strength UP-dosing in Children, Adolescents, and Adults in Daily Practice

NCT07096440 is registered in ClinicalTrials.gov with Allergopharma GmbH & Co. KG as lead sponsor.

NCT NCT07096440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07096440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NOVo-Helisen Depot HoUSe Dust Mites - A Prospective, Multicenter, Noninterventional Clinical Study on the Tolerability and Safety of Short One Strength UP-dosing in Children, Adolescents, and Adults in Daily Practice
Lead sponsor
Allergopharma GmbH & Co. KG
Phase
Observational
Overall status
Not yet recruiting
Start date
July 30, 2025
Completion date
June 30, 2026
Enrollment
105 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

allergic asthma due to dermatophagoides farinae, allergic asthma due to dermatophagoides pteronyssinus, allergic conjunctivitis due to dermatophagoides farinae, allergic conjunctivitis due to dermatophagoides pteronyssinus, allergic rhinitis due to house dust mite